The dream team
Alison Anway is the Chair of Ballard Partners’ Health Policy Advisory Group. Most recently, Alison was the Founder and Principal of the Anway Policy Group (APG), a public policy consulting firm specializing in the healthcare sector.
Alison began her career in health policy in the office of U.S. Senator Pat Roberts (R-KS) where, among other things, she served as Legislative Assistant for Healthcare during the entirety of the consideration and passage of the landmark Affordable Care Act (ACA). The education and experience Alison gained during the two-year period culminating in President Obama’s signing of the ACA into law led to her recruitment by Anthem, the largest Blue Cross Blue Shield plan in America, to lead their Public Policy team dedicated to the federal health plan lines of business. In this role, Alison led a policy division committed to providing policy support to Anthem’s Medicare Advantage, Medicare Part D, Medicaid, and Federal Contracting lines of business.
In 2015, Alison was selected to establish the Public Policy department at UCB Pharma, a global biopharmaceutical company focused on immunology and neurology and headquartered in Brussels, Belgium. This allowed Alison to expand her policy experience into the pharmaceutical sector, in addition to her previous experience with health plans, giving her unique experience and insights into the policy priorities of two of the most powerful health policy constituencies.
In 2018 Alison established APG to provide both federal and state health policy consulting support to a range of health care clients including health plans, pharmaceutical companies, physician groups, and trade associations. Alison now brings this experience to establish Ballard Partners’ Health Policy Advisory Group, allowing Ballard Partners to provide a new suite of policy consulting services including bill analysis and tracking, regulatory summaries and analysis, weekly policy calls, slide deck presentations to internal business partners, policy platform development, policy research, and comment letter drafting.